Cabaletta Bio, Inc.

NASDAQ:CABA

4 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -67.675-52.975-46.289-33.339-16.943-12.202-0.333
Depreciation & Amortization 1.4261.1780.7330.3540.10400
Deferred Income Tax -1.675000-2.26200
Stock Based Compensation 11.3436.8975.8044.3882.30.6060
Change In Working Capital 0.101-4.2995.5811.708-1.506-0.4640.081
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables 1.675-0.0280.9750.5550.2460.2340
Other Working Capital -1.574-4.2714.6061.153-1.752-0.6980.081
Other Non Cash Items 2.9312.8190.0620.1192.2627.3990.252
Operating Cash Flow -53.549-46.38-34.109-26.77-16.045-4.6610
Investing Activities:
Investments In Property Plant And Equipment -0.687-2.453-1.166-0.635-0.69300
Acquisitions Net 0.0220.02500.007000
Purchases Of Investments -84.264-49.7640-11.097000
Sales Maturities Of Investments 62.5257.1653.751000
Other Investing Activites -0.022-0.0250.007-0.007000
Investing Cash Flow -22.451-27.2175.999-7.981-0.69300
Financing Activities:
Debt Repayment 0000-10.09-12.5350
Common Stock Issued 187.63132.98248.9030.02971.21225.1420
Common Stock Repurchased 0.1080.0760.071-0.192-1.293-0.1690
Dividends Paid 0000-10.0900
Other Financing Activities 187.63132.98248.9030.13970.18637.8460.001
Financing Cash Flow 187.63132.98248.903-0.024119.92537.6770.001
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash 111.631-40.61520.793-34.775103.18733.0160.001
Cash At End Of Period 193.23881.607122.222101.429136.20433.0170